(Q43719871)

26 November 2017

title

Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma (English)

1 reference

26 November 2017

David Orlov

2

0 references

author name string

Steven Orlov

1

1 reference

26 November 2017

Michael Shaytzag

3

1 reference

26 November 2017

Mark Dowar

4

1 reference

26 November 2017

Vafa Tabatabaie

5

1 reference

26 November 2017

Philip Dwek

6

1 reference

26 November 2017

Jonathan Yip

7

1 reference

26 November 2017

Cindy Hu

8

1 reference

26 November 2017

Jeremy L Freeman

9

1 reference

26 November 2017

Paul G Walfish

10

1 reference

26 November 2017

publication date

1 June 2009

1 reference

26 November 2017

1 reference

26 November 2017

volume

31

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

782-788

1 reference

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma

26 November 2017

cites work

1 reference

21 January 2018

Cancer statistics, 2007

1 reference

7 January 2021

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

7 January 2021

Natural history, treatment, and course of papillary thyroid carcinoma

1 reference

7 January 2021

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

1 reference

7 January 2021

A 29-year retrospective review of papillary thyroid cancer in one institution.

1 reference

7 January 2021

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer

1 reference

7 January 2021

Application of prognostic scoring systems in differentiated thyroid carcinoma

1 reference

7 January 2021

Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome

1 reference

7 January 2021

An evaluation of prognostic scoring systems in patients with follicular thyroid cancer

1 reference

7 January 2021

Predictors of outcome in patients with papillary thyroid carcinoma

1 reference

7 January 2021

Prognostic factors in patients with differentiated thyroid carcinoma.

1 reference

7 January 2021

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

7 January 2021

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

7 January 2021

Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma

1 reference

7 January 2021

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

7 January 2021

Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma

1 reference

7 January 2021

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome

1 reference

7 January 2021

Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer

1 reference

7 January 2021

Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications

1 reference

7 January 2021

A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group

1 reference

7 January 2021

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group

1 reference

7 January 2021

ATA Guidelines: do patients with stage I thyroid cancer benefit from (131)I?

1 reference

7 January 2021

Is tumor size the best predictor of outcome for papillary thyroid cancer?

1 reference

7 January 2021

Lymph node metastases in differentiated thyroid cancer under 2 cm

1 reference

7 January 2021

Prognostic factors in well-differentiated thyroid carcinoma

1 reference

7 January 2021

Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer

1 reference

7 January 2021

Adverse aspects of small thyroid cancer and need for treatment

1 reference

7 January 2021

Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis

1 reference

7 January 2021

Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma

1 reference

7 January 2021

Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.

1 reference

7 January 2021

Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21020

1 reference

26 November 2017

1 reference